14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $16.60 $18.63 Tuesday, 23rd Apr 2024 ACAD stock ended at $16.74. This is 1.47% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 3.76% from a day low at $16.61 to a day high of $17.23.
90 days $16.60 $29.29
52 weeks $16.60 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Apr 29, 2021 $20.94 $21.22 $20.43 $20.59 1 024 173
Apr 28, 2021 $21.16 $21.18 $20.70 $20.77 1 395 126
Apr 27, 2021 $21.31 $21.37 $20.83 $21.05 1 764 260
Apr 26, 2021 $20.65 $21.65 $20.49 $21.35 1 717 815
Apr 23, 2021 $20.85 $21.47 $20.49 $20.50 1 871 461
Apr 22, 2021 $21.47 $21.74 $20.84 $20.87 1 944 462
Apr 21, 2021 $20.82 $21.53 $20.68 $21.47 1 449 109
Apr 20, 2021 $20.70 $21.25 $20.59 $20.80 1 448 226
Apr 19, 2021 $21.04 $21.42 $20.24 $20.72 2 257 296
Apr 16, 2021 $21.32 $21.40 $20.84 $21.15 4 776 098
Apr 15, 2021 $21.34 $21.57 $21.03 $21.20 2 218 291
Apr 14, 2021 $20.61 $21.78 $20.61 $21.28 2 838 454
Apr 13, 2021 $20.50 $20.90 $20.42 $20.60 1 750 434
Apr 12, 2021 $20.40 $20.71 $20.12 $20.43 2 021 343
Apr 09, 2021 $20.78 $20.86 $20.31 $20.39 1 697 842
Apr 08, 2021 $21.59 $21.60 $20.53 $20.68 2 742 901
Apr 07, 2021 $20.39 $21.68 $20.37 $21.23 4 198 542
Apr 06, 2021 $20.75 $21.18 $20.36 $20.64 7 938 469
Apr 05, 2021 $21.25 $22.07 $20.92 $21.18 11 561 880
Apr 01, 2021 $25.86 $26.28 $25.26 $25.59 1 498 949
Mar 31, 2021 $25.94 $26.56 $25.43 $25.80 1 821 373
Mar 30, 2021 $25.12 $25.98 $24.99 $25.71 1 036 736
Mar 29, 2021 $25.80 $26.12 $25.23 $25.30 1 482 718
Mar 26, 2021 $25.95 $26.30 $25.37 $25.86 1 385 345
Mar 25, 2021 $25.09 $26.20 $24.99 $26.02 1 498 112
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT